The FDA repeatedly told the public that an antiviral with a sterling safety record, ivermectin, should not be used to treat COVID-19 because it was also prescribed, at higher dosages, to livestock.
The agency didn’t appear to show the same concern about correctly dosing the new single-shot mRNA COVID vaccines and is now scrambling to educate healthcare providers not to give children adult-strength jabs even while denying that overdosing is a safety risk.
Read More
After Virginia’s Senate Health and Education Committee voted to push discussions on SB 73 indefinitely, one advocacy group is asking the committee to reconsider the vote.
“Senate Bill 73 provides licensed health care providers with prescriptive authority to prescribe, administer, or dispense Hydroxychloroquine and Ivermectin to a patient with a clinical diagnosis of COVID-19,” Joshua Daniel Pratt, MDiv., the Executive Director for Virginia-based Alliance For Free Citizens wrote to the committee.
Read More
The red state/blue state dichotomy is not simple.
Nowhere is that more apparent than Tennessee where—despite having one of the most conservative electorates in the country—the leadership has been passive at best in responding to the wishes of their supporters during these days of great crisis.
Read More
Fox 26 reporter Ivory Hecker told Project Veritas founder James O’Keefe that the Fox affiliate moved to muzzle her reporting on Hydroxychloroquine because it went against “the corporate narrative,” which has allegedly been influenced by Fox’s advertisers, the Centers for Disease Control and Prevention (CDC), and vaccine companies.
Read More
It turns out that the anti-malaria drug former president Trump famously touted in March of 2020 as a promising treatment for COVID-19, would indeed have been a “game changer” if only it had been widely used.
Use of Hydroxychloroquine to treat the coronavirus can increase survival rates by over 100 percent, according to a new study.
Read More
Think about it: For about five years, anything candidate, president-elect, and President Trump said or did, the media, the Left, and progressive popular culture opposed in Pavlovian fashion.
Anything that Trump touched was ridiculed or discredited—regardless of evidence, data, or cogency. The merits of a Trump policy, a Trump assessment, a Trump initiative were irrelevant—given the primordial hatred of the Left of all things Trump: the president, the person, the family.
Under the reductionist malady of Trump Derangement Syndrome, facts and logic did not matter. Instead, anything not said or done in opposition to Trump empowered the supposed existential Trump threat. Ironically, some of the most deductive and reductionist Trump haters were supposedly professionals, the highly educated, and the self-proclaimed devotees of the Enlightenment. And yet in their uncontrolled aversion and detestation, they suspended all the rules of empiricism, logic, and rationality—and people died as a result.
Read More
Facebook’s independent Oversight Board has reversed the social media platform’s decision to remove an October 2020 post pertaining to the drug hydroxychloroquine in the treatment of COVID-19.
“In October 2020, a user posted a video and accompanying text in French in a public Facebook group related to COVID-19,” the board explained on its website. “The post alleged a scandal at the Agence Nationale de Sécurité du Médicament (the French agency responsible for regulating health products), which refused to authorize hydroxychloroquine combined with azithromycin for use against COVID-19, but authorized and promoted remdesivir. The user criticized the lack of a health strategy in France and stated that “[Didier] Raoult’s cure” is being used elsewhere to save lives. The user’s post also questioned what society had to lose by allowing doctors to prescribe in an emergency a “harmless drug” when the first symptoms of COVID-19 appear.”
Read More
Dr. Simone Gold, a board-certified emergency physician and the founder of America’s Frontline Doctors, has responded to Twitter’s removal of her tweet about treatments for COVID-19 and locking her out of her account.
In her response, Dr. Gold – who also graduated from Stanford Law School after completing her medical degree – called out her temporary Twitter ban, calling the action “another classic case of tech censorship against anyone who speaks out against the media narrative.”
Read More
An anti-malarial drug that President Donald Trump hyped as a potential therapy for the coronavirus helped some patients survive the disease while in the hospital, according to research published Wednesday.
Some of those who received hydroxychloroquine before acute symptoms began were much less likely to die from the virus, according to researchers at Henry Ford Health System in Michigan. Their findings come after other studies determined that the experimental drug provided little or no benefit to people struggling with the coronavirus, or COVID-19.
Read More
In this interview, Dr. Simone Gold and Dr. Dan Wohlgelernter discuss the country’s failure to protect the elderly from the coronavirus and also sort out information around Hydroxychloroquine.
Read More
U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause deadly side effects.
The Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA said the drugs’ unproven benefits “do not outweigh the known and potential risks.”
Read More
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists.
Thursday’s retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.
Read More
Remdesivir, an antiviral medication that was developed by the biopharmaceutical company Gilead Sciences, has been widely touted as the most promising drug to treat COVID-19, even though – so far – the new and expensive drug does not seem to be terribly effective at fighting the disease.
The anti-malaria drug hydroxychloroquine, on the other hand, is cheap, has been used safely for decades, and has shown great promise as a weapon in the fight against the coronavirus – yet after President Trump mentioned it as a promising potential treatment for the disease, the media immediately blasted him for touting an “unproven” and potentially unsafe drug.
Read More
President Donald Trump casually let slip Monday afternoon that he’s been taking hydroxychloroquine, the anti-malarial drug he’s touted as a promising treatment for Covid-19 patients that has become a lightning rod for controversy.
“A couple of weeks ago, I started taking it,” Trump told reporters during a roundtable at the White House with restaurant executives and industry leaders.
“I was just waiting to see your eyes light up when I said this,” Trump added.
Read More